AR041999A1 - Composiciones farmaceuticas que contienen ambroxol y yoduro de isopropamida - Google Patents
Composiciones farmaceuticas que contienen ambroxol y yoduro de isopropamidaInfo
- Publication number
- AR041999A1 AR041999A1 ARP030104095A ARP030104095A AR041999A1 AR 041999 A1 AR041999 A1 AR 041999A1 AR P030104095 A ARP030104095 A AR P030104095A AR P030104095 A ARP030104095 A AR P030104095A AR 041999 A1 AR041999 A1 AR 041999A1
- Authority
- AR
- Argentina
- Prior art keywords
- isopropamide
- pharmaceutical compositions
- effective
- iodure
- compositions containing
- Prior art date
Links
- JTPUMZTWMWIVPA-UHFFFAOYSA-O Isopropamide Chemical compound C=1C=CC=CC=1C(C(N)=O)(CC[N+](C)(C(C)C)C(C)C)C1=CC=CC=C1 JTPUMZTWMWIVPA-UHFFFAOYSA-O 0.000 title abstract 2
- JBDGDEWWOUBZPM-XYPYZODXSA-N ambroxol Chemical compound NC1=C(Br)C=C(Br)C=C1CN[C@@H]1CC[C@@H](O)CC1 JBDGDEWWOUBZPM-XYPYZODXSA-N 0.000 title abstract 2
- 229960005174 ambroxol Drugs 0.000 title abstract 2
- 229960001737 isopropamide Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000003937 drug carrier Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 201000009240 nasopharyngitis Diseases 0.000 abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 2
- 208000024891 symptom Diseases 0.000 abstract 2
- 206010036790 Productive cough Diseases 0.000 abstract 1
- 208000036071 Rhinorrhea Diseases 0.000 abstract 1
- 206010039101 Rhinorrhoea Diseases 0.000 abstract 1
- 230000001078 anti-cholinergic effect Effects 0.000 abstract 1
- 229960003870 bromhexine Drugs 0.000 abstract 1
- OJGDCBLYJGHCIH-UHFFFAOYSA-N bromhexine Chemical compound C1CCCCC1N(C)CC1=CC(Br)=CC(Br)=C1N OJGDCBLYJGHCIH-UHFFFAOYSA-N 0.000 abstract 1
- 239000003172 expectorant agent Substances 0.000 abstract 1
- 230000003419 expectorant effect Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000001734 parasympathetic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000024794 sputum Diseases 0.000 abstract 1
- 210000003802 sputum Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Otolaryngology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Composiciones farmacéuticas que comprenden como compuestos farmacológicamente activos una combinación de una cantidad expectorante efectiva de bromhexina o ambroxol o una de sus sales farmacológicamente aceptable y una cantidad parasimpática (anticolinérgica) efectiva de yoruro de isopropamida. La fórmula cualitativa y cuantitativa de esta invención incluye vehículos o excipientes farmacéuticamente aceptables. La formulación comprende adicionalmente vehículos o excipientes farmacéuticamente aceptables apropiados. Además, esta presentación se refiere al uso de estos compuestos para los distintos síntomas causados por el catarro común. Especialmente, la composición de la presente es efectiva para el tratamiento del esputo y/o moqueo entre los distintos síntomas causados por el catarro común.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02024891A EP1417961A1 (en) | 2002-11-08 | 2002-11-08 | New pharmaceutical compositions containing a combination of ambroxol or bromhexine and isopropamide iodide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR041999A1 true AR041999A1 (es) | 2005-06-08 |
Family
ID=32103916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030104095A AR041999A1 (es) | 2002-11-08 | 2003-11-07 | Composiciones farmaceuticas que contienen ambroxol y yoduro de isopropamida |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1417961A1 (es) |
| JP (1) | JP2006506407A (es) |
| AR (1) | AR041999A1 (es) |
| AU (1) | AU2003301802A1 (es) |
| PE (1) | PE20040670A1 (es) |
| TW (1) | TW200500061A (es) |
| WO (1) | WO2004041263A1 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10332486A1 (de) * | 2003-07-16 | 2005-02-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ambroxol für die Behandlung akuter Schmerzen |
| JP4899304B2 (ja) * | 2004-10-19 | 2012-03-21 | 大正製薬株式会社 | 塩酸アンブロキソール含有内服用固形製剤 |
| JP2007291067A (ja) * | 2006-03-29 | 2007-11-08 | Daiichi Sankyo Healthcare Co Ltd | 医薬組成物 |
| JP2009001548A (ja) * | 2007-05-21 | 2009-01-08 | Daiichi Sankyo Healthcare Co Ltd | トレハロースからなる気道杯細胞過形成抑制剤。 |
| KR101915056B1 (ko) * | 2012-04-10 | 2018-11-07 | 한미약품 주식회사 | 암브록솔, 레보드로프로피진 및 완충제를 포함하는 경구용 액상 제제 및 이의 제조방법 |
| CN102670607A (zh) * | 2012-05-28 | 2012-09-19 | 海南卫康制药(潜山)有限公司 | 复方盐酸氨溴索组合物及其制备方法 |
| CN116459204A (zh) * | 2014-05-23 | 2023-07-21 | 勃林格殷格翰国际有限公司 | 含有盐酸氨溴索的咳嗽糖浆 |
| JP7024248B2 (ja) * | 2016-09-01 | 2022-02-24 | 大正製薬株式会社 | 固形製剤 |
| WO2018182546A1 (en) | 2017-03-27 | 2018-10-04 | İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi | Stabilized pharmaceutical syrup composition comprising terbutaline sulphate and ambroxol hydrochloride |
| JP7765724B2 (ja) * | 2020-06-11 | 2025-11-07 | 大正製薬株式会社 | 固形組成物 |
| JP2022132186A (ja) * | 2021-02-26 | 2022-09-07 | アリナミン製薬株式会社 | 医薬組成物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1204826B (it) * | 1986-03-04 | 1989-03-10 | Chiesi Farma Spa | Composizioni farmaceutiche per inalazione |
| DE3610997A1 (de) * | 1986-04-02 | 1987-10-15 | Krewel Werke Gmbh | Ambroxol-nasenspray |
| CA2115444C (en) * | 1992-06-12 | 2000-10-03 | Yuji Makino | Preparation for intratracheobronchial administration |
| JPH08325142A (ja) * | 1995-05-26 | 1996-12-10 | Sumitomo Pharmaceut Co Ltd | ヨウ化イソプロパミド含有製剤 |
| JPH1045591A (ja) * | 1996-05-22 | 1998-02-17 | Taisho Pharmaceut Co Ltd | 鎮咳剤 |
| JPH1045577A (ja) * | 1996-08-05 | 1998-02-17 | Taisho Pharmaceut Co Ltd | 風邪用咳止め薬 |
| JPH1072349A (ja) * | 1996-08-30 | 1998-03-17 | Taisho Pharmaceut Co Ltd | 鎮咳剤 |
| JPH10298107A (ja) * | 1997-04-25 | 1998-11-10 | Taisho Pharmaceut Co Ltd | 医薬組成物 |
| JP2001233765A (ja) * | 2000-02-24 | 2001-08-28 | Ss Pharmaceut Co Ltd | 感冒薬 |
| JP2003081821A (ja) * | 2001-09-12 | 2003-03-19 | Taisho Pharmaceut Co Ltd | 医薬組成物 |
| JP4695326B2 (ja) * | 2001-12-21 | 2011-06-08 | 第一三共ヘルスケア株式会社 | 鼻炎用医薬組成物 |
-
2002
- 2002-11-08 EP EP02024891A patent/EP1417961A1/en not_active Withdrawn
-
2003
- 2003-10-31 WO PCT/EP2003/012125 patent/WO2004041263A1/en not_active Ceased
- 2003-10-31 AU AU2003301802A patent/AU2003301802A1/en not_active Abandoned
- 2003-10-31 JP JP2004548828A patent/JP2006506407A/ja active Pending
- 2003-11-06 PE PE2003001121A patent/PE20040670A1/es not_active Application Discontinuation
- 2003-11-07 AR ARP030104095A patent/AR041999A1/es unknown
- 2003-11-07 TW TW092131255A patent/TW200500061A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003301802A1 (en) | 2004-06-07 |
| JP2006506407A (ja) | 2006-02-23 |
| WO2004041263A1 (en) | 2004-05-21 |
| PE20040670A1 (es) | 2004-11-18 |
| TW200500061A (en) | 2005-01-01 |
| EP1417961A1 (en) | 2004-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY27740A1 (es) | Nuevos compuestos | |
| UY38602A (es) | Compuestos tricíclicos condensados | |
| UY29825A1 (es) | Derivados sustituidos de 3h-imidazol-(4,5 b (beta))piridina-2-il benzoatos y benzamidas, composiciones farmacéuticas que los contienen y aplicaciones | |
| CL2009001980A1 (es) | Combinacion farmaceutica que comprende un derivado de quinolina y uno o mas de otros agentes antimicobacterianos; composicion farmaceutica que la comprende; y uso para el tratamiento de una infeccion por una cepa de mycobacterium resistente a farmacos (divisional de la solicitud 1290-05). | |
| ECSP10010693A (es) | Compuestos pirazólicos 436 | |
| ECSP088974A (es) | Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3) | |
| AR042095A1 (es) | Compuesto 4-oxoquinolina y aplicacion del mismo como inhibidor de integrasa de vih | |
| AR127050A1 (es) | Compuestos espirocíclicos | |
| AR041999A1 (es) | Composiciones farmaceuticas que contienen ambroxol y yoduro de isopropamida | |
| CR8859A (es) | Derivados de piridina | |
| ECSP045474A (es) | 1-(aminoalquil)-3-sulfonilazaindoles como ligandos de 5-hidroxitriptamina-6 | |
| ECSP066990A (es) | Formulaciones con liberación controlada de principio activo que contienen vardenafilo | |
| ECSP088973A (es) | Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3) | |
| AR051904A1 (es) | Peptidos con actividad agonista del receptor del neuropeptido-2 (y2r) | |
| CO2019010029A2 (es) | Compuestos de tipo imidazo[4,5-c]quinolin-2-ona deuterados y su uso en el tratamiento del cáncer | |
| AR054347A1 (es) | Combinaciones terapeuticas para el tratamiento o la prevencion de la depresion | |
| DOP2006000243A (es) | Derivados de pirazina | |
| PE20070521A1 (es) | 7-[2-[4-(6-FLUORO-3-METIL-1,2-BENCISOXAZOL-5-IL)-1-PIPERAZINIL]ETIL]-2-(1-PROPINIL)-7H-PIRAZOL-[4,3-E]-[1,2,4]-TRIAZOL-[1,5-C]-PIRIMIDIN-5-AMINA COMO ANTAGONISTA DEL RECEPTOR DE ADENOSINA A2a | |
| CR9751A (es) | Formulaciones topicas con contenido de o-desmetilvenlafaxina (odv) o sus sales. | |
| UY28979A1 (es) | Derivados de hidrocloruros de 3-carboxamida, composiciones farmacéuticas que los contienen, procedimiento de preparación y su uso, útiles como inhibidores selectivos de gsk3 | |
| UY29181A1 (es) | Derivados de bencenosulfonamidas n-sustituidos, composiciones que los contienen, procesos de preparación y aplicaciones | |
| ES2582660T3 (es) | Sidnoniminas - inhibidores específicos de la recaptación de la dopamina y su uso en el tratamiento de los trastornos relacionados con la dopamina | |
| DOP2025000099A (es) | Enlazadores-cargas útiles de adc derivados de exatecán, composiciones farmacéuticas, y usos de los mismos | |
| AR056517A1 (es) | Composiciones y metodos farmaceuticos utilizando temozolomida y un inhibidor de la proteina quinasa | |
| UY27324A1 (es) | Nuevas sales de napsilato i |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |